HighTower Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,250
Closed -$91K 3971
2024
Q1
$91K Buy
35,250
+8,750
+33% +$21.4K ﹤0.01% 3170
2023
Q4
$54K Sell
26,500
-19,840
-43% -$36.2K ﹤0.01% 3290
2023
Q3
$80K Buy
46,340
+4,000
+9% +$7.1K ﹤0.01% 3149
2023
Q2
$83K Buy
42,340
+15,000
+55% +$35.1K ﹤0.01% 3109
2023
Q1
$76K Sell
27,340
-1,000
-4% -$2.86K ﹤0.01% 2989
2022
Q4
$98K Buy
28,340
+2,000
+8% +$5.71K ﹤0.01% 2943
2022
Q3
$67K Buy
26,340
+1,500
+6% +$4.78K ﹤0.01% 2839
2022
Q2
$60K Hold
24,840
﹤0.01% 2885
2022
Q1
$102K Buy
24,840
+4,499
+22% +$23.8K ﹤0.01% 2985
2021
Q4
$262K Sell
20,341
-12,349
-38% -$137K ﹤0.01% 2564
2021
Q3
$352K Sell
32,690
-2,950
-8% -$26.8K ﹤0.01% 2306
2021
Q2
$325K Buy
35,640
+2,240
+7% +$20.7K ﹤0.01% 2323
2021
Q1
$315K Buy
33,400
+9,900
+42% +$136K ﹤0.01% 2270
2020
Q4
$93K Buy
23,500
+4,500
+24% +$13.6K ﹤0.01% 2358
2020
Q3
$50K Buy
+19,000
New +$70.5K ﹤0.01% 2302

Other funds holding GRTS

HighTower Advisors's GRTS Position: Q2 2024 in Review

HighTower Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 35,250 shares — an estimated $91K sold.

HighTower Advisors first reported a position in GRTS in Q3 2020 and held it in 15 quarters. The position peaked at $352K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • HighTower Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 35,250 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $91K.
  • HighTower Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • HighTower Advisors's Gritstone bio, Inc. Common Stock position peaked at $352K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.